Lupus Nephritis
📧 Sign up to get email alerts when something new happens for Lupus Nephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-04-01Clinical Trial Update: Study of LJP 394 in Lupus Patients With History of Renal Disease [Phase 3]
A Phase 3 study of LJP 394 in patients with systemic lupus erythematosus and a history of renal disease has been terminated.
-
CLINICAL_TRIALS research · 2009-03-05Clinical Trial Update: Cyclophosphamide in Lupus Nephritis
An update on a clinical trial evaluating cyclophosphamide for lupus nephritis in systemic lupus erythematosus, sponsored by the University o…
-
CLINICAL_TRIALS trial_result · 2008-10-29Clinical Trial Update: Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis [Phase 3]
A Phase 3 randomized multicenter trial evaluated tacrolimus for induction and maintenance therapy in lupus nephritis; the study has complete…
-
FDA approval · 2008-07-29FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic mycophenolate mofetil under an Original Application, making a generic immunosuppressan…
-
CLINICAL_TRIALS withdrawal · 2008-05-29Clinical Trial Update: Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis [Phase 3]
A Phase 3 trial evaluating steroids for maintenance of remission in proliferative lupus nephritis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2008-04-16Clinical Trial Update: Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating mesenchymal stem cell transplantation as a treatment for lupus nephritis. The current status of …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis [Phase 2]
A Phase 2 clinical trial of BG9588, an anti-CD40L antibody, for lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Cyclophosphamide and Fludarabine to Treat Lupus Nephritis [Phase 1]
A Phase 1 trial evaluating cyclophosphamide and fludarabine for lupus nephritis has completed.
-
FDA approval · 2007-12-20FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil) submitted by Genentech, Inc.
-
CLINICAL_TRIALS research · 2007-12-06Clinical Trial Update: A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis [Phase 2]
Pilot Phase 2 study evaluating the efficacy and safety of tacrolimus in the treatment of refractory lupus nephritis.
-
CLINICAL_TRIALS trial_result · 2007-01-31Clinical Trial Update: Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study [Phase 3]
A Phase 3, placebo-controlled, double-blind multicenter trial evaluating tacrolimus (FK506) for lupus nephritis has completed.
-
EMA withdrawal · 2006-10-13EMA Application withdrawn: Riquent (abetimus) — La Jolla Limited
The EMA withdrew the application for Riquent (abetimus) by La Jolla Limited for lupus nephritis.
-
CLINICAL_TRIALS trial_result · 2006-09-25Clinical Trial Update: Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease [Phase 3]
A Phase 3 trial of abetimus sodium (LJP 394) for lupus nephritis and systemic lupus erythematosus has completed, reporting on safety and eff…